Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 5 versus DEXTROSE 5 AND POTASSIUM CHLORIDE 0 15.
Head-to-head clinical analysis: DEXTROSE 5 versus DEXTROSE 5 AND POTASSIUM CHLORIDE 0 15.
DEXTROSE 5% vs DEXTROSE 5% AND POTASSIUM CHLORIDE 0.15%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose 5% provides a source of calories and water for intravenous administration. It is metabolized to carbon dioxide and water, yielding energy. Dextrose solutions exert osmotic effects and can increase blood glucose levels.
Dextrose serves as a source of calories and water for hydration, and is metabolized to carbon dioxide and water, yielding energy. Potassium chloride provides potassium ions to maintain electrolyte balance, necessary for nerve conduction, muscle contraction, and acid-base regulation. The combination replenishes fluid and electrolytes in patients with hypokalemia and dehydration.
Intravenous infusion; 5% dextrose in water (D5W) is typically administered at a rate of 100-200 mL/hour to provide 50-100 g of glucose per day for maintenance hydration and minimal caloric support in adults.
Intravenous infusion of 1000-2000 mL/day (providing 50-100 g dextrose and 1.5-3 g potassium chloride) at a rate of 50-100 mL/hour; adjust based on fluid and electrolyte requirements.
None Documented
None Documented
0.5-1 hour (endogenous glucose); intravenous infusion half-life is variable due to continuous cellular uptake and metabolism; clinical context: rapid clearance via insulin-mediated cellular uptake and glycolysis.
Dextrose: not applicable (rapidly metabolized). Potassium: distribution half-life ~1 h, terminal half-life ~8 h (in patients with normal renal function); prolonged in renal impairment.
Renal: 100% (D-glucose and its metabolites, including CO2 and water); less than 1% excreted unchanged in urine under normal conditions; fecal excretion negligible.
Potassium: >90% renal (glomerular filtration and tubular secretion). Dextrose: metabolized to CO2 and water; negligible renal excretion (<5%).
Category C
Category C
IV Fluid
IV Fluid